Overview

A Study of Ponesimod in Healthy Adult Participants

Status:
Recruiting
Trial end date:
2022-12-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of steady-state carbamazepine (CBZ; a strong pregnane X receptor [PXR] agonist) on the pharmacokinetics (PK) of ponesimod following a gradual up-titration regimen in healthy adult participants.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Pharmaceutica N.V., Belgium
Treatments:
Carbamazepine
Ponesimod